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Abstract
Background Improved survival of preterm neonates has
increased the incidence of retinopathy of prematurity (ROP)
in many middle-income countries.
Aim This study aimed to verify the main risk factors for the
development of ROP according to different gestational age
(GA) groups.
Methods A prospective cohort study including infants
weighing ≤1,500 g or GA ≤32 weeks at birth was conducted.
The main clinical outcomes were the occurrence of any stage
of ROP and severe ROP. The perinatal variables considered
for the study were: birth weight; GA; gender; to be small for
GA (SGA); weight gain from birth to the sixth week of life;
use of oxygen in mechanical ventilation or nasal CPAP;
multiple gestations; therapeutic use of surfactant, indometh-
acin, and erythropoietin; occurrence of sepsis, meningitis,
intraventricular hemorrhage, and patent ductus arteriosus;
need for and volume of blood transfusion; and 10-min
Apgar score. The patients were divided into three groups
according to GA: (group 1) infants of GA ≤28 weeks at
birth (n=100); (group 2) infants of GA=29–31 weeks at
birth (n=215); and (group 3) infants of GA ≥32 weeks
at birth (n=152).
Results A total of 467 newborn infants were included.
Mean BW and GA in the total cohort were 1,216.5 g
(±278.3) and 30.3 weeks (±2.2), respectively. Gestational
age groups were not matched for BW and SGA. Any stage
of ROP occurred in 111 patients (23.8%) and 24 (5.1%)
patients developed severe ROP. Only BW and volume of
blood transfusion were significant factors for the occur-
rence of any stage of ROP in all groups. In group 1, GA,
the twin situation, and use of erythropoietin were statisti-
cally significant factors. In group 2, only GA and need for
blood transfusion were significant. In group 3, use of
oxygen in mechanical ventilation, sepsis, and need for blood
transfusion were significant for ROP onset. The logistic
regressiondeterminedthatpatientsingroups2and3wereless
likely to develop ROP than patients in group 1.
Conclusions Patients in groups 1 and 2 developed ROP
due to general immaturity, whereas bigger babies, of
GA ≥32 weeks, developed ROP because they were “sicker”
babies with more comorbidities.
Keywords Prematurity.Retinopathyofprematurity.
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Introduction
Retinopathy of prematurity (ROP) is a leading cause of
childhood preventable blindness, and its earlier detection
allows specific prevention and treatment approaches. Inves-
tigations on risk factors (RF) for ROP onset are, therefore,
extremely important for ophthalmologists involved in
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infants.
Several institution- and population-based studies have
investigated RF for the occurrence of ROP [1–8]. However,
for the most part, data are unified into a single homoge-
neous cohort of patients, i.e., patients are not grouped
according to gestational age (GA), although it is well
known that preterm babies with lower GA are more likely
to develop ROP and that clinical conditions of patients of
lower GA are quite different from those of more mature
infants (of greater GA) [9, 10].
This study aimed to analyze the prevalence and possible
risk factors for ROP onset among patients attending a
neonatal center in southern Brazil, dividing patients into
different groups according to GA.
Methods
Patients
A prospective cohort study was conducted including preterm
infants with a BW ≤1,500 g or GA ≤32 weeks at birth
admitted to Hospital de Clínicas de Porto Alegre (HCPA),
southern Brazil, between October 2002 and December 2008.
The sample included all preterm infants who survived from
the initial ophthalmological examination, performed between
the fourth and sixth week after birth, to 45 weeks of
postmenstrual age. There were no exclusion criteria. Preterm
infants were divided into three groups according to GA:
(group1)patientsofGA≤28weeksatbirth;(group2)patients
of GA between 29 and 31 weeks at birth; and (group 3)
patients of GA ≥32 weeks at birth.
All patients underwent an eye examination, which
consisted of binocular indirect ophthalmoscopy following
dilated pupil examination in both eyes associated with
0.5% tropicamide and 2.5% phenylephrine eye drops,
using 28-diopter lens (Nikon, Melville, NY, USA), and a
newborn infant eyelid speculum (Alfonso Eye Speculum,
Storz, Bausch & Lomb Inc., San Dimas, CA, USA).
Scleral indentation was performed when necessary.
All patients were examined in the neonatal intensive care
unit (NICU) and, after hospital discharge, attended outpa-
tient follow-up appointments until 45 weeks of postmenst-
rual age, or until effective stabilization of retinopathy was
achieved after treatment. The screening sessions and the
follow-up were performed according to the Brazilian
guidelines to detect and treat ROP, which recommend
screening for all babies born with a BW ≤1,500 g or
GA ≤32 weeks and for those babies with risk factors such
as respiratory distress syndrome, sepsis, intraventricular
hemorrhage, babies who needed blood transfusions, and for
those being born from multiple gestations. The initial
ophthalmological examination should be performed
between the fourth and sixth weeks of life and should be
repeated weekly or more frequent according to the findings
until full vascularization of the peripheral retina is observed
or until 45 weeks of postmenstrual age. The Brazilian
guidelines state treatable ROP in ROP zone I, any stage
with plus disease, ROP in zone I, stage 3 with no-plus or
ROP in zone II, stages 2 or 3 with plus disease or at least, at
threshold ROP [11].
Outcome and variables
Clinical outcomes included the onset of any stage of ROP
and the development of ROP severe enough to require
treatment. Staging of disease was recorded according to
the 1984/1987 International Classification of ROP [12, 13]
and always corresponded to the highest stage of ROP
found during patient follow-up. Severe ROP and threshold
ROP were defined according to the Multicenter Trial of
Cryotherapy for Retinopathy of Prematurity [14]. All eye
examinations were performed by the same authors (JBFF,
GUE, and PGBS).
The following continuous variables were prospectively
analyzed: birth weight (BW); GA (evaluated by obstetric
history, early obstetric ultrasound, and confirmed by
newborn infant clinical examination); weight gain in grams
from birth to the sixth week of life (defined as the baby’s
weight measured at completed 6 weeks of life minus the
BW); 10-min Apgar score; volume of blood transfusion;
and units of erythropoietin administered. The categorical
variables were also prospectively analyzed: infant being
appropriate or small for GA (SGA <10th percentile for
GA); gender; the twin situation (multiple or single
gestation); use of oxygen in mechanical ventilation or by
nasal continuous positive airway pressure (CPAP); use of
indomethacin, surfactant, and erythropoietin; occurrence of
sepsis, meningitis, patent ductus arteriosus, and any stage
intraventricular hemorrhage; and need for blood transfu-
sion. Sepsis, meningitis, and intraventricular hemorrhage
were diagnosed by clinical examination, microbiological
culture, and cranial ultrasound, respectively. The diagnosis
of clinical sepsis was based on the presence of three or
more of the following: apnea, difficult breathing, cyanosis,
tachycardia or bradycardia, perfusion deficit or shock;
irritability, lethargy, hypotonia and seizures; abdominal
distention, vomits, dietary intolerance, gastric residue,
hepatomegaly, idiopathic jaundice, thermal instability,
petechiae or purpura; and a general poor appearance.
Babies with positive blood cultures for coagulase-negative
staphylococci and clinical sepsis had the following defi-
nitions to distinguish proven infection from contaminants:
two positive blood cultures drawn within 2 days of each
other or one positive blood culture and elevated C-reactive
894 Graefes Arch Clin Exp Ophthalmol (2010) 248:893–900protein>10 mg/l within 2 days of blood culture. For all
other pathogens, proven sepsis was defined by the presence
of the organism in the blood culture.
Statistical methods and ethics
All statistical analyses were conducted using the SSPS
software (SPSS 14.0 for Windows, SPSS Inc., Chicago, IL,
USA). Incidence of ROP was calculated for all three
groups. One-way ANOVA was used to analyze continuous
variables between groups, and the Chi-square test was used
to compare categorical variables. Variables considered for
logistic regression were selected based on their significance
after univariate analysis. Receiver operating characteristic
(ROC) curves were used to demonstrate the predictive
value of each significant variable for any stage or for severe
ROP. The results were considered significant for p<0.05,
with 95% confidence intervals.
The study protocol was approved by the Research Ethics
Committee of HCPA, no. 03–248, on Aug 20, 2003. The
protocol also conforms to the provisions of the Declaration
of Helsinki in 1995 (as revised in Edinburgh, 2000).
Results
A total of 467 preterm infants, corresponding to around
93% of all patients with a BW ≤1,500 g or GA ≤32 weeks
admitted to the institution were screened for ROP and were
included in this study. Mean BW and GA for the total
cohort was 1,216.5 g (±278.3) and 30.3 weeks (±2.2),
respectively. A total of 111 (23.8%) patients developed any
stage ROP, and 24 (5.1%) patients developed severe ROP.
Of these, 23 patients were treated with diode laser
photocoagulation. The sample was divided into three
different groups according to GA. The characteristics of
the included patients are described in Table 1.
Incidence of ROP was significantly higher in group 1
and significantly lower in group 3, p<0.001 (Table 2).
After univariate analysis, the significant variables for
any stage ROP were, in group 1, BW, GA, weight gain,
volume of transfused blood, and the twin situation; in group
2, BW, volume of transfused blood, weight gain, and need
for blood transfusion; and in group 3, BW, volume of
transfused blood, use of oxygen therapy in mechanical
ventilation, sepsis, and need for blood transfusion.
The variables infant SGA or appropriate for GA, Apgar
index, gender, use of oxygen by nasal CPAP, use of
indomethacin, use of surfactant, use of erythropoietin,
occurrence of meningitis, patent ductus arteriosus, units of
erythropoietin, and intraventricular hemorrhage were not
considered significant factors for the development of any
stage ROP in all three study groups (Table 3).
For severe ROP, only BW was a significant RF in groups
1 and 2, whereas in group 1, GA and need for blood
transfusion, were statistically significant for the develop-
ment of severe ROP. Among patients in group 2, in addition
to BW, need for and volume of blood transfusion, units of
erythropoietin were significant RF for the occurrence of
severe ROP. In group 3, no statistically significant RFs
were observed (Table 4).
The logistic regression determined that patients in
groups 2 and 3 were less likely to develop any stage ROP
than patients in group 1. In group 1, GA showed
significance at p=0.024 and OR=0.547 (95%CI 0.324–
Table 1 Characteristics of the three groups divided according to GA
Group 1 Group 2 Group 3 p-value
Number of patients (%) 100 (21.4%) 215 (46.0%) 152 (32.5%)
GA in weeks: range, (mean) (SD) 24–28 (27.1) (1.0) 29–31 (30.2) (0.7) 32–37 (32.7) (1.1) <0.001 ANOVA
BW in grams: range, (mean) (SD) 505–1,650 (956) (238.6) 650–1,830 (1231.3) (244.0) 845–2,000 (1367.1) (222.1) <0.001 ANOVA
Male gender 41 (41%) 98 (45.6%) 65 (42.8%) 0.730 NS
SGA <10th percentile 12 (12%) 69 (32.1%) 121 (79.6%) <0.001
BW birth weight; GA gestational age; NS not significant; SD standard deviation; SGA small for gestational age
Table 2 Incidence of ROP in the three groups divided according to GA
Group 1 Group 2 Group 3 p-value
Without ROP 57 (57%) 165 (76.7%) 134 (88.2%) <0.001
ROP 43 (43%) 50 (23.3%) 18 (11.8%)
ROP 1 12 (12%) 27 (12.6%) 11 (7.2%) <0.001
ROP 2 17 (17%) 14 (6.5%) 6 (3.9%) <0.001
ROP 3
a 14 (14%) 7 (3.3%) 1 (0.7%) <0.001
ROP 4
a 0 (0%) 1 (0.5%) 0 (0%) NS
ROP 5
a 0 (0%) 1 (0.5%)
b 0 (0%) NS
GA gestational age; NS not significant; ROP retinopathy of prematurity
aSevere ROP
bGroup 2 infant who did not attend follow-up appointment due to
discharge from the Neonatal Center
Graefes Arch Clin Exp Ophthalmol (2010) 248:893–900 895T
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blood transfusion and units of erythropoietin. In group 2,
volume of blood transfusion showed significance at p=
0.009 and OR=1.017 (95%CI 1.004–1.030), when adjusted
for GA and need for blood transfusions. In group 3, volume
of blood transfusion showed significance at p=0.043 and
OR=1.032 (95%CI 1.001–1.063), when adjusted for GA,
use of oxygen in mechanical ventilation, and need for blood
transfusions (Table 5). It was not possible to perform the
logistic regression for severe ROP due to the reduced
number of this outcome in all three groups.
Area under the ROC curves for the most important and
significant study variables is described in Table 6.
All patients weighing more than 1,500 g and of greater
than 32 weeks’ GA at birth who developed ROP showed
spontaneous regression of the disease and did not need to
undergo treatment.
Of the 24 patients who developed severe ROP, 23 were
treated with transpupillary diode laser photocoagulation in
the retinal periphery, and one patient was not treated
(Table 7). This patient developed ROP 5 and total bilateral
blindness for not attending follow-up appointment due to
NICU discharge. Among the 23 babies who required
treatment for severe ROP, 22 had received blood trans-
fusions and 20 erythropoietin therapy, 20 had sepsis, 15 had
undergone mechanical ventilation, 13 received indometha-
cin, ten surfactant, eight had intraventricular hemorrhage,
three had meningitis, three had persistent ductus arteriosus,
and four were born from multiple gestation.
Discussion
The incidence of severe ROP during the study period was
5.1%, which is a very low percentage, even for countries
with established standards of excellence in perinatal care
[15].
Gilbert et al. [16] suggested that ROP prevails among
preterm infants weighing less than 1,000 g at birth in
industrialized countries and has emerged as a major cause
of childhood blindness in developing countries, such as
Brazil, and in several other places in Latin America, Asia,
For any stage of ROP Area p-value 95% CI
Lower bound Upper bound
BW (g) 0.709 <0.001 0.654 0.765
GA (weeks) 0.695 <0.001 0.639 0.752
Weight gain (g) 0.719 <0.001 0.667 0.771
Oxygen in MV 0.590 0.006 0.527 0.653
Sepsis 0.572 0.028 0.510 0.633
Need for transfusions 0.684 <0.001 0.627 0.740
Volume of transfused blood (ml) 0.749 <0.001 0.693 0.805
For severe ROP
BW (g) 0.816 <0.001 0.729 0.903
GA (weeks) 0.793 <0.001 0.701 0.885
Weight gain (g) 0.761 <0.001 0.647 0.875
Need for transfusions 0.750 <0.001 0.683 0.817
Volume of transfused blood (ml) 0.815 <0.001 0.759 0.872
Table 6 ROC curves for ROP
in the whole cohort
ROC receiver operating charac-
teristic; ROP retinopathy of
prematurity; CI confidence
interval; BW birth weight; GA
gestational age; MV mechanical
ventilation
Table 5 Logistic regression adjusted for risk factors for any stage of ROP in the three groups
Group 1 Group 2 Group 3
GA p=0.024; OR: 0.547
(95%CI 0.324–0.925)
NS NS
Twin situation NS
Volume of blood transfusion (ml) NS p=0.009; OR: 1.017
(95%CI 1.004–1.030)
p=0.043; OR: 1.032
(95%CI 1.001–1.063)
Units of erythropoietin NS
Need for blood transfusion NS NS
Use of oxygen in MV NS
ROP retinopathy of prematurity; CI confidence interval; GA gestational age; MV mechanical ventilation; NS not significant; OR odds ratio
Graefes Arch Clin Exp Ophthalmol (2010) 248:893–900 897and Eastern Europe due to a sharp increase in the survival
of very low birth weight (VLBW) preterm infants [17, 18].
Although these figures vary greatly among countries,
survival rates of infants between 27 and 28 weeks’ GA at
birth have been reported to reach approximately 90% [19].
This is not the present situation in the middle-income
countries regarding survival rates. In a previous article, we
related survival rates of 88.7% among babies with a
BW >1,000 and ≤1,500 g (or with mean GA 30.9±1.9),
and only 47.8% among babies with a BW ≤1.000 g (or with
mean GA 28.5±2.1) at our institution [10].
Studies suggest that the incidence and severity of ROP
are inversely related to BW and GA, with a few diagnoses
of severe ROP (stage 3, threshold disease, or greater)
being identified among infants with a BW >1,500 g or
GA >32 weeks [20]. In population-based studies, the
incidence of severe ROP was previously related as being
higher among infants of less than 28 weeks’ GA or
weighing less than 1,000 g [21, 22], although there are
some reports of severe ROP among infants of 34–35 weeks’
GA and a BW >1,500 g, mainly in the presence of
complications after birth [23].
In our study, the patients were grouped according to the
GA. Group 1 comprised extremely premature babies
(GA ≤28 weeks at birth). This GA range was chosen
because similarity of clinical conditions usually happens
among this group of patients. Group 2 comprised premature
patients with GA of 29–31 weeks. In this range, usually, are
inserted most of the patients screened for ROP in the
middle-income countries context where standards of peri-
natal care have been improving in recent years. In group 3
were included babies over GA 32 weeks at birth. This is
also a very homogenous group (regarding GA and BW)
including bigger babies but with more comorbidities, some
of them previously related with the onset of ROP, as sepsis
[24], intraventricular hemorrhage [25], blood transfunded
patients [26], or others. In our cohort of 467 patients, severe
ROP occurred in 14% of group 1 patients, in 4.3% of group 2
patients, and in only 0.7% of group 3 patients, these
differences being considered statistically significant (p<
0.001) (Table 2). No cases of severe ROP were observed
among patients with a BW >1,500 g or GA >32 weeks at
birth in our study. Our analysis revealed the influence of GA
on the risk factors for occurrence of ROP. The population-
based study conducted by Holmström et al. in Sweden,
published in 1993, corroborates the statement concerning the
importance of GA for the onset of ROP [27]. A number of
studies analyzing perinatal RF for ROP have been published
but only a few have analyzed the dynamic behavior of risk
factors in relation to GA as has been performed in the
present study. Koerner et al. in 1986 [28], published a very
interesting study regarding the influence of GA and retinal
maturity on the statistical behavior of risk factors for ROP
and related that below 32 weeks GA, acidosis, hyperoxemia,
GA, paCO2 levels and multiple birth are strong regressors
while above 31 weeks GA, the most important regressor are
multiple birth and acidosis and that GA and FiO2 >0.4 are
much less influential on onset of ROP. The final conclusion
of this study stated that it is the proportion of infants with an
immature retinal vascularization in populations of given GA
rather than the GA itself that is responsible for the widely
varying importance of certain RF for ROP [28].
In our study, the main RF associated with the develop-
ment of any stage of ROP among infants of lower GA
(group 1) were: low GA, low BW, the twin situation,
weight gain from birth to the sixth week of life, and volume
of blood transfusion. Weight gain, need for and volume of
blood transfusion, GA, and BW were statistically signifi-
cant RF among patients in group 2. Among babies in group
Table 7 Characteristics of the patients treated for severe ROP from
2002 to 2008
Case GA
(weeks)
BW (g) Gender Study
group
GA at
treatment
(weeks)
1 25 620 F 1 36
2 25 755 F 1 36
3 26 625 F 1 36
4 26 700 F 1 36
5 26 710 F 1 36
6 26 890 F 1 37
7 26 1,080 F 1 37
8 27 635 F 1 36
9 27 920 F 1 34
10 27 1,055 M 1 39
11 28 730 M 1 41
12 28 750 M 1 38
13 28 850 M 1 37
14 28 1,260 M 1 37
15 29 990 M 2 39
16 30 870 M 2 40
17 30 920 F 2 38
18 30 935 M 2 37
19 30 1,500 F 2 40
20 31 780 M 2 40
21 31 900 M 2 40
22 31 1,230 M 2 40
23 32 1,315 M 3 41
Mean 28.3 918.3 38
SD 2.3 231.7 2.0
Min 25 620 34
Max 32 1,500 41
ROP retinopathy of prematurity; GA gestational age; BW birth weight;
SD standard deviation
898 Graefes Arch Clin Exp Ophthalmol (2010) 248:893–9003, who were bigger and more mature, but sicker, need for
and volume of blood transfusion, need for oxygen therapy
in mechanical ventilation, and occurrence of sepsis were
significant factors for the development of any stage of ROP.
Birth weight, GA, and oxygen therapy are often
considered the most important RF for ROP, but some
studies have not found a significant correlation between
BW and GA, as independent factors for onset of ROP, after
logistic regression analyses. This situation might be
explained within a statistical scope, since all patients
included in ROP studies already have lower BW and GA
when compared to a normal population, and mutual
influence of variables varies greatly according to the
statistical models selected for logistic regression in each
study [29]. It is also worth noting that most patients in
groups 1 and 2 in our study received oxygen therapy in
mechanical ventilation or in nasal CPAP (Tables 3 and 4).
Patients in group 3 disclosed more comorbidities as sepsis,
bronchopulmonary dysplasia needing oxygen therapy in
mechanical ventilation, use of erythropoietin and need for
multiple blood red cells transfusions. Dammann et al. [30]
investigatedthe role sepsis playsinthe occurrenceof ROPand
concluded that, in their cohort of patients, severe ROP was
absentininfantsofgreaterthan29weeks’GA; however, when
sepsis was present in these babies, there was an increased risk
fordevelopment of any stage of ROP and severe ROP. Of the
23 patients who underwent laser treatment for severe ROP in
our study, 20 (87%) had developed proven sepsis.
Weightgainfrombirthtothesixthweekoflifeisarecently
mentioned RF for predicting ROP. Our previously published
article [31], and others [32, 33], disclosed the usefulness of
this parameter in predicting any stage or severe ROP with
some weeks in advance of onset of threshold ROP. The areas
under the ROC curve of the weight gain, 0.719 and 0.76,
respectively, in the whole cohort in our study, again
disclosed that weight gain can be a better predictor for any
stage of ROP or for severe, rather than other RFs.
HCPA is a university-based tertiary hospital located in
Porto Alegre, southern Brazil, a city with a total population
of approximately 3 million inhabitants. HCPA NICU has 20
intensive care beds. The prevalence of ROP at HCPA has
been previously reported as occurring in 24.7% of infants
with a BW ≤1,500 g or GA ≤32 weeks between 2002 and
2006 [34] and our survival rates reach around 88.7%
among babies with a BW >1,000 and ≤1,500 g and only
47.8% among babies with a BW≤1,000 g [10]. Of the 24
patients who developed severe ROP and threshold disease
severe enough to require treatment in our cohort at HCPA,
14 patients were in group 1, nine were in group 2, and only
one patient was in group 3 (the group of bigger, but sicker,
babies). However, none of these patients developed
aggressive posterior ROP or ROP in zone I. No cases of
aggressive posterior ROP were detected in our cohort,
maybe by chance or, perhaps, by the higher mean of BW
and GA of our patients if compared in these same
parameters with data from the industrialized countries with
lower BW and GA patients. It is of current knowledge that
aggressive posterior ROP seems to occur especially among
smaller and more immature patients.
Sincethecohortofbabiesinthe28-weekorlessGA(group
1) was only 100 babies with a mean GA of 27.1 weeks
correspondingtoonly24.1%oftheentirecohort,theremaybe
limited generalizability of the results of this study to countries
where a larger proportion of babies in a less than 26-week
gestation group are surviving to develop ROP.
Conclusions
The general ROP incidence of 23.8% and severe ROP
requiring laser treatment of 5.1% found in our study agrees
within the variation reported by other institution-based
studies. In group 3, only one preterm infant with a BW of
1,315 g and GA of 32 weeks at birth needed laser treatment.
Based on the dynamic analysis of the RF involved in the
developmentofany stage of ROP and ROP severe enough to
require treatment, we can hypothesize that smaller and more
immature babies (lower GA and BW) are more likely to
develop ROP solely due to general immaturity and not
necessarily because they are “sicker” babies, whereas bigger
and more mature babies can develop ROP due to the
presence of a higher number of or more severe comorbidities
(or because they were “sicker” babies) after premature birth.
It is worth mentioning that our observations are based on
data from a single neonatal center and should not be
extrapolated to patients from centers with neonatal care
procedures different from those applied in a university-
based tertiary hospital.
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